Kuros Biosciences Ltd.

Company Description

---

With more than 150 years of combined research experience, we feel well-established as leaders in orthobiologics, but we're never content with resting on our laurels. Instead, we continue to forge beyond the accepted solutions for spinal fusion. Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Served area

---

Worldwide

Headcount

---

58

Headquarters

---

Wagistrasse 25, 8952 Schlieren – Switzerland

Shares outstanding

---

32,811,378

IPO

---

Oct. 29, 2002

Stock exchange(s)

---

SIX Swiss Exchange